Metrics
- Impact factor
- 2.7+0 Clarivate JCR
- WoS quartile
- Q3 Clarivate JCR, best category
- SJR
- 0.414Q3 SCImago
- h-index
- 73
- CAS tier
- Tier 3 Chinese Academy of Sciences
- Citations per paper
- 2.46 last 2 years
- Articles per year
- 95
- Self-citation
- 9.5%
- Fee (APC), est.
- $2,923 estimated, check the journal
About this journal
- ISSN
- 0021-8820 (print) · 1881-1469 (online)
- Publisher
- Springer Nature
- Country
- Japan · Western Europe
- Indexed in
- SCIE
- Access
- Hybrid · 11.8% gold OA
- Founded
- 2005
- Frequency
- Monthly
- Original research
- 94.1%
- Subject areas
- Pharmacology, Toxicology and Pharmaceutics
- Categories
- Medicine, Immunology
- Common topics
- Chemistry, Biology, Genetics, Biochemistry, Microbiology
Similar journals
- Q3WoS
Tetrahedron Letters
Impact factor 1.4h-index 159SJR 0.28 - Q3WoS
Current Protocols
Impact factor 2.5h-index 157SJR 1.04 - Q3SJR
Handbook of Experimental Pharmacology
h-index 119SJR 0.17 - Q3WoS
Journal of Clinical Pharmacology
Impact factor 2.2h-index 106SJR 0.77 - Q3WoS
Biological & Pharmaceutical Bulletin
Impact factor 1.8h-index 104SJR 0.52 - Q3WoS
Cancer Chemotherapy and Pharmacology
Impact factor 2.5h-index 100SJR 0.85
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals